Trial Profile
A Phase 2b/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Mucoadhesive Buccal Tablet to Placebo to Prevent Chemoradiotherapy-induced Severe Oral Mucositis in Patients With Oropharyngeal Cancer
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 11 Nov 2023
Price :
$35
*
At a glance
- Drugs Clonidine (Primary)
- Indications Stomatitis
- Focus Registrational; Therapeutic Use
- Acronyms VOICE
- Sponsors Monopar Therapeutics; Valerio Therapeutics
- 19 Apr 2023 This trial has been discontinued in Spain, according to European Clinical Trials Database record.
- 10 Apr 2023 This trial has been discontinued in Germany, according to European Clinical Trials Database record.
- 27 Mar 2023 Primary endpoint (To demonstrate the efficacy of HCl MBT to prevent SOM in OPC patients receiving CRT.) has not been met, according to a Monopar Therapeutics media release.